Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2014 /
Role of genomics in assessing risk, especially in ovarian cancer

5th - 9th Apr 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 01.05.14
Views: 2629

Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA

Dr Sellers talks to ecancertv at the AACR conference about his work in the field of molecular epidemiology. He stresses the need for an open multidisciplinary approach when gathering and sharing data and looking at how cancer can be prevented.

Specifically, he talks about how genomics can better inform us, not only to genetic susceptibility but the very mechanism of cancer itself.

He pays particular attention to ovarian cancer and the measures that can be taken to best prevent the disease in different individuals by better detecting their individual risk, noting the advances that have been made in this area.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence